Merck Tbk PT

Merck Tbk PT EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Merck Tbk PT (MERK.JK) as of Oct 18, 2026 is 320.43 B IDR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 201.15 B IDR — a change of 59.30% (higher).

EBITDA

320.43 BIDR

YoY

59.30%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Merck Tbk PT is 2025 320.43 B IDR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Merck Tbk PT was 2024 201.15 B IDR. It decreases by 59.30% higher compared to the previous year.

The Merck Tbk PT EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
49.85 B IDR
Jan 1, 2019
128.52 B IDR
Jan 1, 2020
119.41 B IDR
Jan 1, 2021
201.70 B IDR
Jan 1, 2022
247.72 B IDR
Jan 1, 2023
208.48 B IDR
Jan 1, 2024
201.15 B IDR
Jan 1, 2025
320.43 B IDR
The Merck Tbk PT EBITDA history
YEAREBITDAYoY
320.43 BIDR+59.30%
201.15 BIDR-3.51%
208.48 BIDR-15.84%
247.72 BIDR+22.81%
201.70 BIDR+68.92%
119.41 BIDR-7.09%
128.52 BIDR+157.84%
49.85 BIDR-76.43%
211.47 BIDR-2.29%
216.43 BIDR+13.80%
190.19 BIDR-6.53%
203.48 BIDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Merck Tbk PT is 320.43 B IDR in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Merck Tbk PT changed from 201.15 B IDR to 320.43 B IDR, representing a 59.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s IDR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Merck Tbk PT historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Merck Tbk PT

All Key Metrics — Merck Tbk PT